Cargando…
Improvement in Gemcitabine-Induced Thrombotic Microangiopathy with Rituximab in a Patient with Ovarian Cancer: Mechanistic Considerations
Gemcitabine is a potent and widely used anticancer drug. We report a case of gemcitabine-induced thrombotic microangiopathy (GCI-TMA), a known but not widely recognized complication of gemcitabine use, and our experience of treating GCI-TMA with rituximab. A 74-year-old woman was referred to our cli...
Autores principales: | Murugapandian, Sangeetha, Bijin, Babitha, Mansour, Iyad, Daheshpour, Sepehr, Pillai, Biju G., Thajudeen, Bijin, Salahudeen, Abdulla K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4519601/ https://www.ncbi.nlm.nih.gov/pubmed/26266248 http://dx.doi.org/10.1159/000435807 |
Ejemplares similares
-
Epidemiology of Glomerular Disease in Southern Arizona: Review of 10-Year Renal Biopsy Data
por: Murugapandian, Sangeetha, et al.
Publicado: (2016) -
Contemporary Monoclonal Antibody Utilization in Glomerular Diseases
por: Mansour, Iyad, et al.
Publicado: (2023) -
Role of tolvaptan in the management of hyponatremia in patients with lung and other cancers: current data and future perspectives
por: Thajudeen, Bijin, et al.
Publicado: (2016) -
Outcome of Patients with Infective Endocarditis who were Treated with Extracorporeal Membrane Oxygenation and Continuous Renal Replacement Therapy
por: John, Santhosh G., et al.
Publicado: (2014) -
Leukocyte Cell-Derived Chemotaxin 2-Associated Renal Amyloidosis: A Case Report
por: Kaur, Gagandeep, et al.
Publicado: (2017)